14 01/06/2024 31/05/2025 2025-05-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-06-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 10300940 2024-06-01 2025-05-31 10300940 2025-05-31 10300940 2024-05-31 10300940 2023-06-01 2024-05-31 10300940 2024-05-31 10300940 2023-05-31 10300940 core:FurnitureFittingsToolsEquipment 2024-06-01 2025-05-31 10300940 bus:RegisteredOffice 2024-06-01 2025-05-31 10300940 bus:LeadAgentIfApplicable 2024-06-01 2025-05-31 10300940 bus:Director1 2024-06-01 2025-05-31 10300940 core:FurnitureFittingsToolsEquipment 2024-05-31 10300940 core:FurnitureFittingsToolsEquipment 2025-05-31 10300940 core:RetainedEarningsAccumulatedLosses 2023-06-01 2024-05-31 10300940 core:RetainedEarningsAccumulatedLosses 2024-06-01 2025-05-31 10300940 core:WithinOneYear 2025-05-31 10300940 core:WithinOneYear 2024-05-31 10300940 core:ShareCapital 2025-05-31 10300940 core:ShareCapital 2024-05-31 10300940 core:RetainedEarningsAccumulatedLosses 2025-05-31 10300940 core:RetainedEarningsAccumulatedLosses 2024-05-31 10300940 core:ShareCapital 2023-05-31 10300940 core:RetainedEarningsAccumulatedLosses 2023-05-31 10300940 core:PreviouslyStatedAmount core:ShareCapital 2025-05-31 10300940 core:FurnitureFittingsToolsEquipment 2024-05-31 10300940 bus:Director1 2025-05-31 10300940 bus:Director1 2024-05-31 10300940 bus:SmallEntities 2024-06-01 2025-05-31 10300940 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 10300940 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 10300940 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 10300940 bus:FullAccounts 2024-06-01 2025-05-31 10300940 core:OtherRelatedParties 2024-06-01 2025-05-31 10300940 core:OtherRelatedParties 2025-05-31 10300940 core:OtherRelatedParties 2024-05-31
Company registration number: 10300940
RMS Medical Supplies Ltd
Unaudited filleted financial statements
31 May 2025
RMS Medical Supplies Ltd
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
RMS Medical Supplies Ltd
Directors and other information

| Director | Mr Ramis Gunduz
| Company number | 10300940
| Registered office | 187 High Road Leyton
|  | London
|  | E15 2BY
| Accountants | Benchmark Accounting Services Ltd
|  | 187 High Road Leyton
|  | London
|  | E15 2BY

RMS Medical Supplies Ltd
Report to the director on the preparation of the
unaudited statutory financial statements of RMS Medical Supplies Ltd
Year ended 31 May 2025
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 May 2025 which comprise the statement of financial position, statement of changes in equity and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Benchmark Accounting Services Ltd
187 High Road Leyton
London
E15 2BY
26 March 2026
RMS Medical Supplies Ltd
Statement of financial position
31 May 2025

|  |  | 2025 |  |  |  | 2024 |  |
|  | Note | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |  |
Tangible assets |  | 5 | 6,587 |  |  |  | 5,048 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  |  |  | 6,587 |  |  |  | 5,048
Current assets |  |  |  |  |  |  |  |  |
Stocks |  |  | 67,281 |  |  |  | 67,281 |  |
Debtors |  | 6 | 806,721 |  |  |  | 664,713 |  |
Cash at bank and in hand |  |  | 938,325 |  |  |  | 1,523,242 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  | 1,812,327 |  |  |  | 2,255,236 |  |
Creditors: amounts falling due |  |  |  |  |  |  |  |  |
within one year |  | 7 | ( 44,210) |  |  |  | ( 274,740) |  |
|  |  | _______ |  |  |  | _______ |  |
Net current assets |  |  |  |  | 1,768,117 |  |  |  | 1,980,496
|  |  |  |  | _______ |  |  |  | _______
Total assets less current liabilities |  |  |  |  | 1,774,704 |  |  |  | 1,985,544
|  |  |  |  | _______ |  |  |  | _______
Net assets |  |  |  |  | 1,774,704 |  |  |  | 1,985,544
|  |  |  |  | _______ |  |  |  | _______
Capital and reserves |  |  |  |  |  |  |  |  |
Called up share capital |  |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  |  | 1,774,604 |  |  |  | 1,985,444
|  |  |  |  | _______ |  |  |  | _______
Shareholder funds |  |  |  |  | 1,774,704 |  |  |  | 1,985,544
|  |  |  |  | _______ |  |  |  | _______

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 26 March 2026 , and are signed on behalf of the board by:
Mr Ramis Gunduz
Director
Company registration number: 10300940
RMS Medical Supplies Ltd
Statement of changes in equity
Year ended 31 May 2025

|  | Called up share capital |  | Profit and loss account | Total |  |  |  |  |
|  | £ |  | £ | £ |  |  |  |  |
At 1 June 2023 |  | 100 |  | 1,423,347 | 1,423,447 |  |  |  |  |
(Loss)/profit for the year |  |  |  | 648,211 | 648,211 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total comprehensive income for the year |  | - |  | 648,211 | 648,211 |  |  |  |  |
Dividends paid and payable |  |  |  | ( 86,114) | ( 86,114) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total investments by and distributions to owners |  | - |  | ( 86,114) | ( 86,114) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
At 31 May 2024 and 1 June 2024 |  | 100 |  | 1,985,444 | 1,985,544 |  |  |  |  |
(Loss)/profit for the year |  |  |  | ( 57,282) | ( 57,282) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total comprehensive income for the year |  | - |  | ( 57,282) | ( 57,282) |  |  |  |  |
Dividends paid and payable |  |  |  | ( 153,558) | ( 153,558) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total investments by and distributions to owners |  | - |  | ( 153,558) | ( 153,558) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
At 31 May 2025 |  | 100 |  | 1,774,604 | 1,774,704 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |

RMS Medical Supplies Ltd
Notes to the financial statements
Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 187 High Road Leyton, London, E15 2BY.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
No material uncertainties related to events or conditions that may casts significant doubt on the ability of the company to continue as a going concern have been identified by the director.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Fittings fixtures and equipment | - | 25 % | straight line

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 14 (2024: 15 ).
5. Tangible assets

|  | Fixtures, fittings and equipment | Total |  |  |  |  |
|  | £ | £ |  |  |  |  |
| Cost |  |  |  |  |  |  |
| At 1 June 2024 | 10,613 | 10,613 |  |  |  |  |
| Additions | 5,270 | 5,270 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| At 31 May 2025 | 15,883 | 15,883 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| Depreciation |  |  |  |  |  |  |
| At 1 June 2024 | 5,565 | 5,565 |  |  |  |  |
| Charge for the year | 3,731 | 3,731 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| At 31 May 2025 | 9,296 | 9,296 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| Carrying amount |  |  |  |  |  |  |
| At 31 May 2025 | 6,587 | 6,587 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| At 31 May 2024 | 5,048 | 5,048 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |

6. Debtors

|  |  | 2025 | 2024
|  |  | £ | £
| Trade debtors |  | 49,172 | 54,672
| Other debtors |  | 757,549 | 610,041
|  |  | _______ | _______
|  |  | 806,721 | 664,713
|  |  | _______ | _______

7. Creditors: amounts falling due within one year

|  |  | 2025 | 2024
|  |  | £ | £
| Corporation tax |  | - | 215,886
| Social security and other taxes |  | 11,340 | 31,189
| Other creditors |  | 32,870 | 27,665
|  |  | _______ | _______
|  |  | 44,210 | 274,740
|  |  | _______ | _______

8. Directors advances, credits and guarantees

|  | Balance brought forward and o/standing | Balance brought forward and o/standing
|  | 2025 | 2024
|  | £ | £
| Mr Ramis Gunduz | 304,144 | 304,144
|  | _______ | _______

9. Related party transactions
During the year the company entered into the following transactions with related parties:

|  | Transaction value |  | Balance owed by/(owed to) |
|  | 2025 | 2024 | 2025 | 2024
|  | £ | £ | £ | £
| Other related parties | - | - | 282,524 | 160,648
|  | _______ | _______ | _______ | _______